Compass Therapeutics, Inc. (CMPX)

Price & Market Data

Price: $2.04

Daily Change: +$0.115 / 5.60%

Daily Range: $1.88 - $2.15

Market Cap: $372,781,984

Daily Volume: 5,945,503

Performance Metrics

1 Week: 2.33%

1 Month: -63.15%

3 Months: -68.70%

6 Months: -59.28%

1 Year: -2.71%

YTD: -63.15%

About Compass Therapeutics, Inc. (CMPX)

Get current market data for Compass Therapeutics, Inc. (CMPX). Price: 2.04, daily change: +$0.115 / 5.60%. Market cap: 372,781,984. Performance YTD, 1-week, 3-month.

Company Details

Employees: 39

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops antibody-based therapeutics for the treatment of various human diseases in the United States. The company's lead product candidate, tovecimig, is a bispecific antibody that targets delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF-A), which are critical to angiogenesis and tumor vascularization. It also develops CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells; CTX-8371, a bispecific inhibitor that targets programmed cell death protein-1 (PD-1) and ligand PD-L1 checkpoint inhibitor antibodies; and CTX-10726, a bispecific antibody that targets PD-1 and VEFG-A. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Selected stocks

Top KingWin Ltd (WAI)

Turn Therapeutics Inc. (TTRX)

Immutep Limited (IMMP)

Nuvation Bio Inc. (NUVB)

Data I/O Corporation (DAIO)